anti-MDS1 and EVI1 Complex Locus (MECOM) 抗体

Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. 再加上,我们可以发MDS1 and EVI1 Complex Locus 蛋白 (9)MDS1 and EVI1 Complex Locus 试剂盒 (4)和数多这个蛋白质的别的产品。

列出全部抗体 基因 基因ID UniProt
MECOM 2122 Q03112 , Q13465
MECOM 14013 Q9Z1L8
MECOM 294924  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • 在线下订单

antibodies-online.cn销售最多的anti-MDS1 and EVI1 Complex Locus 抗体

Showing 10 out of 144 products:

产品编号 适用 宿主 标记 应用范围 图像 规格 交付 价格 详细
Cow 非结合性 IHC, WB Host: Rabbit Target Name: EVI1 Sample Tissue: Human 293T Antibody Dilution: 1.0ug/ml Host: Rabbit Target Name: MECOM Sample Tissue: Human 293T Whole Cell Antibody Dilution: 1ug/ml 100 μL 2至3个工作日
Cow 非结合性 WB WB Suggested Anti-EVI1 Antibody Titration: 0.2-1 ug/mlELISA Titer: 1:62500Positive Control: Hela cell lysate 100 μL 2至3个工作日
非结合性 WB WB Suggested Anti-EVI1 Antibody Titration: 0.2-1 ug/ml ELISA Titer: 1:1562500 Positive Control: Human brain 100 μL 2至3个工作日
非结合性 WB WB Suggested Anti-MDS1 Antibody Titration:  1.25ug/ml  ELISA Titer:  1:312500  Positive Control:  Raji cell lysate 100 μL 2至3个工作日
山羊 非结合性 ELISA, WB   100 μg 6至7个工作日
非结合性 EIA, WB Western blot analysis of EVI1 Antibody (N-term) in CEM cell line lysates (35ug/lane). This demonstrates the EVI1 antibody detected the EVI1 protein (arrow). 0.4 mL 6至8个工作日
非结合性 ELISA, IHC, WB 100 μL Available
非结合性 EIA, WB Western blot analysis of MDS1 Antibody (Center) in mouse NIH-3T3 cell line lysates (35ug/lane). This demonstrates the MDS1 antibody detected the MDS1 protein (arrow). 0.4 mL 6至8个工作日
非结合性 WB 100 μL 11至14个工作日
山羊 非结合性 ELISA, WB 100 μg 11至14个工作日

引用最多的anti-MDS1 and EVI1 Complex Locus 抗体

  1. Human Polyclonal MECOM Primary Antibody for ELISA, WB - ABIN4270672 : Konrad, Karger, Hackl, Schwarzinger, Herbacek, Wieser: Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes. in Journal of leukocyte biology 2009 (PubMed)

更多抗MDS1 and EVI1 Complex Locus的相互作用对抗体

Human MDS1 and EVI1 Complex Locus (MECOM) interaction partners

  1. neonatal bone marrow failure syndrome with multiple congenital abnormalities, including limb defects, due to a constitutional deletion of 3' MECOM

  2. Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML.

  3. For higher-risk myelodysplastic syndrome (MDS) patients, EVI1-high patients have poorer survival rate compared with EVI1-low patients. Moreover, EVI1-high was an adverse prognostic marker for MDS with excess blasts subtype. Taken together, EVI1 overexpression is a poor prognostic marker for higher-risk MDS group and could be included in risk stratification for MDS patients.

  4. These findings suggest that in colon cancer EVI1 is dispensable for epithelial-mesenchymal transition, however, is required for metastasis.

  5. The evidence has been provided, that miR-9 is significantly downregulated in a subset of pediatric AML patients with high expression of EVI1, and that miR-9 has a critical role in EVI1-induced leukemogenesis in pediatric patients, thereby establishing the role of miR-9 as a tumor suppressor in the pathogenesis of EVI1-induced myeloid leukemia.

  6. Our data indicated that EVI1 played an oncogenic role in nasopharyngeal carcinoma growth and metastasis

  7. Furthermore, EVI1 was also likely to target the promoter region of calreticulin (CRT) in vitro. It was concluded that EVI1 can affect epithelial mesenchymal transitionassociated genes by regulating the expression of CRT in breast cancer. The results revealed that EVI1 may be a potential effective therapeutic target in breast cancer.

  8. Germline mutation in MECOM is associated with congenital bone marrow failure without a radial abnormality.

  9. report on the first familial germline mutation in MDS1 and EVI1 complex locus (MECOM); finding extends MECOM germline mutation associated phenotypes and proposes MECOM as a novel HMMS candidate gene.

  10. Expression of ecotopic viral integration site 1 (EVI1) is positively correlated with talin1 (TLN1) in both chronic myeloid leukemia (CML)-chronic phase (CP) and CML-blast crisis (BC) cases.

  11. EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma.

  12. We propose the term MECOM-associated syndrome for this heterogeneous hereditary disease and inclusion of MECOM sequencing in the diagnostic workup of congenital bone marrow failure.

  13. Overall, we show the importance of performing detailed molecular cytogenetic analysis of MECOM to enable appropriate management of high-risk pediatric myeloid neoplasms.

  14. presence of 3q26.2/EVI1 rearrangements in MDS/MPN is associated with rapid disease progression, poor response to treatment, and a poor prognosis

  15. High EVI1 expression predicts poor outcome in Acute myeloid leukemia with intermediate cytogenetic risk in patients receiving chemotherapy.

  16. The relationship between EVI1 and microRNAs in human malignancies. [review]

  17. Fisher's exact SubID was used to reveal EVI1 as a transcriptional regulator of INPP4B in AML; a finding which was validated in vitro. Next, we used CoxPH SubID to conduct a pan-cancer analysis of INPP4B's prognostic significance

  18. Letter/Case Report: ETV6/MECOM gene fusion in therapy-related acute myeloid leukemia with t(3;12) and monosomy 7.

  19. These findings highlight a novel mechanism for hepatitis B virus X-induced hepatocarcinogenesis through transcription factor EVI1 and its target lncRNAs

  20. Findings represent the first global genome-wide study of EVI1 DNA binding associated with whole transcriptome expression analysis. Results reveal several important genes with an ETS-like binding motif, is involved in terminal myeloid differentiation, cell cycle regulation and apoptosis

Mouse (Murine) MDS1 and EVI1 Complex Locus (MECOM) interaction partners

  1. EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription.

  2. These findings highlight a novel mechanism for hepatitis B virus X-induced hepatocarcinogenesis through transcription factor EVI1 and its target lncRNAs

  3. Gata2 heterozygous deletion confers selective advantage to EVI1-expressing leukemia cell expansion in recipient mice

  4. EVI1 acts as a regulator of its own expression, highlighting the complex regulation of EVI1, and open new directions to better understand the mechanisms of EVI1 overexpressing leukemias.

  5. the DNA sequences to which EVI1 binds at +35 and +37 kb and show that mutation of one of these releases Cebpa from EVI1-induced suppression.

  6. Evi1(+)DA-3 cells modified to express an intracellular form of GM-CSF, acquired growth factor independence and transplantability and caused an overt leukemia in syngeneic hosts, without increasing serum GM-CSF levels.

  7. Survivin partially regulates HSC function by modulating the Evi-1 transcription factor and its downstream targets

  8. Thrombopoietin/MPL signaling confers growth and survival capacity to CD41-positive cells in a mouse model of Evi1 leukemia.

  9. Prdm16 and Prdm3 control postnatal BAT identity and function.

  10. Mice carrying a hypomorphic Evi1 allele are embryonic viable but exhibit severe congenital heart defects.

  11. Lack of ME leads to a complex defect in both osseous and non-osseous musculoskeletal tissues.

  12. PR-domain protein ME has an essential role in mixed-lineage leukemia (MLL) fusion protein (MFP) leukemia

  13. Cotransduction of Evi1 and the shortest isoform of C/EBPbeta, liver inhibitory protein (LIP), induced acute myeloid leukemia with short latencies in a mouse bone marow transplantation model.

  14. Transient Evi1 transfection inhibited TGF-beta-induced transcriptional activity and reversed the growth inhibitory effect of TGF-beta in MC-26 mouse colon cancer cells.

  15. Evi1 is a key regulator of adipogenic competency

  16. Data identify Prdm3 and Prdm16 as H3K9me1 methyltransferases and expose a functional framework in which anchoring to the nuclear periphery helps maintain the integrity of mammalian heterochromatin.

  17. EVI1 is a critical player in tumor growth in a subset of MLL-rearranged acute myeloid leukemia.

  18. our study provides important insights into the novel role for EVI1 in negatively regulating NF-kappaB-dependent inflammation

  19. the results indicate that Evi-1 is expressed in a stage-specific manner during ovarian follicular development and may be involved in early follicle development.

  20. Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity.

Zebrafish MDS1 and EVI1 Complex Locus (MECOM) interaction partners

  1. nephrogenesis in zebrafish is regulated by interactions between retinoic acid, mecom, and Notch signaling

  2. Prdm3 and prdm16 are strongly expressed in the pharyngeal arches during cranioskeletal development, and their knockdown leads to defects in both the viscerocranium and the neurocranium.

Xenopus laevis MDS1 and EVI1 Complex Locus (MECOM) interaction partners

  1. Evi-1 is detected by in situ hybridization in the pronephric tissue, the brain and in neural crest derivatives of the head and neck

MDS1 and EVI1 Complex Locus (MECOM) 抗原简介


The protein encoded by this gene is a transcriptional regulator and oncoprotein that may be involved in hematopoiesis, apoptosis, development, and cell differentiation and proliferation. The encoded protein can interact with CTBP1, SMAD3, CREBBP, KAT2B, MAPK8, and MAPK9. This gene can undergo translocation with the AML1 gene, resulting in overexpression of this gene and the onset of leukemia. Several transcript variants encoding a few different isoforms have been found for this gene.

Gene names and symbols associated with MECOM

  • MDS1 and EVI1 complex locus (MECOM) 抗体
  • MDS1 and EVI1 complex locus (Mecom) 抗体
  • MDS1 and EVI1 complex locus (mecom) 抗体
  • MDS1 and EVI1 complex locus L homeolog (mecom.L) 抗体
  • AML1-EVI-1 抗体
  • D630039M04Rik 抗体
  • evi-1 抗体
  • evi1 抗体
  • im:7140716 抗体
  • Jbo 抗体
  • Mds 抗体
  • Mds1 抗体
  • Mds1-Evi1 抗体
  • mecom 抗体
  • mecom-a 抗体
  • mecom-b 抗体
  • prdm3 抗体
  • xEvi-1 抗体
  • Znfpr1b1 抗体

Protein level used designations for MECOM

AML1-EVI-1 fusion protein , MDS1 and EVI1 complex locus protein EVI1 , MDS1 and EVI1 complex locus protein MDS1 , ecotropic virus integration site 1 protein homolog , myelodysplasia syndrome-associated protein 1 , oncogene EVI1 , zinc finger protein Evi1 , ecotropic viral integration site 1 , ecotropic virus integration site 1 protein , myelodysplasia syndrome 1 homolog , myelodysplasia syndrome 1 protein homolog , PR domain containing 3 , MDS1 and EVI1 complex locus , MDS1 and EVI1 complex locus protein EVI1-like , MDS1 and EVI1 complex locus protein EVI1-A , ecotropic virus integration site 1 protein homolog-A , myelodysplasia syndrome 1-ectopic viral integration site 1

2122 Homo sapiens
424997 Gallus gallus
532209 Bos taurus
14013 Mus musculus
497407 Danio rerio
460837 Pan troglodytes
488148 Canis lupus familiaris
698603 Macaca mulatta
100343228 Oryctolagus cuniculus
100403987 Callithrix jacchus
100591579 Nomascus leucogenys
294924 Rattus norvegicus
734157 Xenopus laevis
anti-MDS1 and EVI1 Complex Locus (MECOM) 抗体 精选生产商